Metraipolis › archive › dc_f3c74bea6ea4
CRISPR-Cas is beneficial in plasmid competition, but limited by competitor toxin-antitoxin activity when horizontally transferred — Europe PMC PMID:41712626
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41712626
- DOI
- 10.1371/journal.pbio.3003658
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T15:49:10.556Z
- SHA-256 of the archived text
a164e0919ea841ac8534d7db2559a52f4f96ce712e4a13f7b881073962b58a13- Stable URL of this page
https://metraipolis.com/documento/dc_f3c74bea6ea4
How to cite
CRISPR-Cas is beneficial in plasmid competition, but limited by competitor toxin-antitoxin activity when horizontally transferred — Europe PMC PMID:41712626 — Europe PMC (en), https://europepmc.org/article/MED/41712626 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f3c74bea6ea4 (Metraipolis archive dc_f3c74bea6ea4, sha256 a164e0919ea841ac8534d7db2559a52f4f96ce712e4a13f7b881073962b58a13)
BibTeX
@misc{dcf3c74bea6ea4,
title = {CRISPR-Cas is beneficial in plasmid competition, but limited by competitor toxin-antitoxin activity when horizontally transferred — Europe PMC PMID:41712626},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41712626},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f3c74bea6ea4; sha256 a164e0919ea841ac8534d7db2559a52f4f96ce712e4a13f7b881073962b58a13},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41712626. Agents can read the archived copy with the MCP tool read_document.